Stromal Vascular Fraction (SVF) in orthopedics

What is the Stromal Vascular Fraction (SVF)?

SVF is the stromal-vascular fraction of adipose tissue. It contains a mixture of different cell types (including mesenchymal precursor cells, endothelial cells, perivascular cells, immune cells) as well as extracellular matrix components and soluble messenger substances. In contrast to pure cell preparations, SVF is a heterogeneous concentrate obtained from your own fatty tissue.

How might SVF work? Above all via paracrine effects - i.e. via messenger substances that modulate inflammation, influence the local microenvironment and support repair processes. The aim is not to “re-grow” an entire joint, but rather to potentially relieve pain, promote tissue balance and improve function. A guaranteed effect cannot be derived from this.

• Origin: own fatty tissue (autologous)
• Components: cell mix + matrix + messenger substances
• Goal: anti-inflammatory and regulating micro-environment
• Status: predominantly the subject of research in orthopedics

Regulatory framework in Germany/EU

The production of SVF by enzymatic isolation is usually considered more than minimal manipulation in the EU and falls under the scope of Advanced Therapy Medicinal Products (ATMP). This requires special manufacturing and approval requirements. This form is therefore usually not available in routine outpatient care in Germany and is reserved for clinical studies or specialized centers.

Mechanical procedures without enzymes (e.g. microfragmentation of fatty tissue) are considered minimally manipulated and are possible under certain conditions, depending on the indication and legal classification. However, these differ clearly from enzymatically obtained SVF.

• Enzymatic SVF: usually ATMP – usually not available outside of studies
• Mechanically prepared fatty tissue (e.g. microfat/nanofat): minimally manipulated, different legal assessment
• Advice is crucial: We provide you with transparent information about feasibility, evidence and alternatives

Who is SVF being studied for?

SVF is researched in the specialist literature primarily for joint wear (osteoarthritis) and tendon problems. The selection of suitable patients is crucial - and conservative standard therapies are always the starting point.

• Osteoarthritis: especially knees (gonarthrosis) and shoulders, sometimes hips and ankles
• Tendons: chronic tendinopathies (e.g. Achilles tendon, patellar tendon) – data are still limited
• Cartilage damage: focal cartilage defects examined in individual cases, evidence heterogeneous

Possible suitability (theoretical/study-based) is more likely for mild to moderate osteoarthritis if conservative measures have not helped sufficiently over several months. In late stages with significant joint deformity, the expected benefit is limited - surgical procedures may make more sense here.

• Absolute contraindications: acute infections, unexplained fevers, active tumor diseases, local skin infections
• Relative contraindications: coagulation disorders, uncontrolled diabetes, greatly increased cardiovascular risks
• Principle: individual benefit-risk assessment after thorough diagnostics

Conservative basic therapy first

Before considering regenerative procedures, we exhaust guideline-oriented conservative options. The aim is to reduce pain, improve function and increase everyday resilience.

• Targeted physiotherapy and active training (strength, coordination, mobility)
• Stress control in everyday life and during sport
• Weight management if you are overweight (significantly relieves pressure on joints)
• Drug-based pain and inflammation modulation in a low effective dose
• Orthotics/insoles, taping, manual procedures
• Injection therapies such as PRP (autologous blood) or hyaluronic acid – depending on the findings

Many patients are already achieving noticeable improvement with this combination. Regenerative options are only considered if the basic measures were consistently implemented and yet insufficiently effective.

SVF treatment process (general study protocol)

Since enzymatically obtained SVF is usually only available in a study context in Germany, the following process is based on typical study protocols. Details vary depending on the center and study requirements.

Important: The decision for or against such treatment should never be made hastily. It belongs in the hands of experienced specialists who provide transparent information.

Effectiveness: What does the current evidence say?

The study situation on SVF is dynamic, but not yet conclusive. There are prospective studies and smaller randomized controlled studies that demonstrate improvements in pain and function in selected osteoarthritis patients. At the same time, results are heterogeneous, samples are often small and follow-up times are limited.

• Short to medium-term improvements have been described – not for all those affected
• Comparisons to PRP or hyaluronic acid show some similar and some different effects
• Long-term data and robust, large RCTs are lacking in many indications
• Overall, evidence on tendon problems is still thin

Reputable medicine means: identifying opportunities realistically, accepting limitations and defining individual goals. There is no guarantee of success.

Risks and side effects

As with any intervention, there are risks. They are often mild and temporary, serious complications are rare - but can occur. Careful explanation is mandatory.

• At the removal site: bruising, swelling, tenderness, temporary sensory disturbances
• At the injection site: irritation reaction, swelling, pain, in rare cases infection
• General: allergy-like reactions to excipients/local anesthetics possible
• Specific to enzymatic processing: strict quality requirements required; Implementation only in suitable structures
• Theoretical risks: e.g. B. Influencing existing tumor diseases - therefore not used in active tumor diseases

The individual risk constellation (previous illnesses, medications such as blood thinners, metabolism) is carefully assessed before therapy.

Useful alternatives: Microfat, Nanofat and PRP

Because enzymatic SVF is usually not regularly available in Germany, more established alternatives are coming into focus. These include minimally manipulated fatty tissue procedures (e.g. microfragmented fat – microfat; nanofat) and PRP (autologous blood). These processes differ in extraction, composition and potential mechanism of action.

• Microfat: mechanically processed autologous fat that preserves the tissue architecture; et al. examined for osteoarthritis and tendon problems
• Nanofat: very finely filtered fraction of fatty tissue with a high concentration of soluble factors
• PRP: platelet-rich plasma from your own blood; good database for knee osteoarthritis and some tendinopathies

Which option is right depends on the findings, goals and the individual risk profile. We advise you transparently - always with conservative measures as a basis.

Aftercare and rehabilitation

The success of treatment depends heavily on structured follow-up care. Even the best injection cannot compensate for inadequate everyday and training control.

• Short-term relief for a few days, then gradually increasing the load
• Accompanying physiotherapy with a focus on strength, coordination and mobility
• Individual adaptation of sport and everyday life – “smart” instead of “hard” training
• Regular follow-up checks to fine-tune therapy and training

Costs and reimbursement

The enzymatic production of SVF is not usually part of standard care in Germany and is generally not available outside of clinical studies. Mechanical fatty tissue procedures (e.g. Microfat/Nanofat) and PRP are mostly self-pay services. Private insurance companies sometimes make decisions on a case-by-case basis. Before each measure, you will receive transparent cost and information information.

Your contact point in Hamburg

We take the time to thoroughly clarify your symptoms - from diagnostics to conservative treatment planning to honest advice on regenerative options. You can find us at Dorotheenstraße 48, 22301 Hamburg. You can easily request appointments via Doctolib or by email.